kinase inhibitors,phosphatase inhibitors,drug discovery and development,biotechnology,structure based drug design,david hangauer,allen barnett,lyn dyster, johnson lau,src kinase and cancer,next generation cancer drugs,substrate site kinase inhibitors,small molecule kinase inhibitors,buffalo ny biotechnology company,peptide binding site of kinase and phosphatase enzymes,mimetica,signal transduction and cancer,signal transduction inhibitors,angiogenesis,metastasis,tumor growth, pharmaceutical development, anti-cancer

kinex pharmaceuticals is a drug discovery and development company that is focused on next generation anti-cancer drugs. platform technology, mimetica, generates small molecules, that bind in the peptide site of kinase and phosphatase enzymes.